PPA Honoured to Support Kyowa Kirin in the PBS Listing of Crysvita

PPA was honoured to support Kyowa Kirin in the listing of their first PBS entry, Crysvita, for the treatment of X-linked hypophosphataemia (XLH).

Today, Health Minister Mark Butler updated the Parliament during question time on the new and updated medicines the Government will be supporting under the PBS, including Crysvita.

Around 230 patients per year could benefit from this listing. Without subsidy, Australian families might pay more than $360,000 per year of treatment.

Australia will be the first country in the world to offer this life changing treatment for both children and adults.

Related Posts

PPA Supports Awareness for World Hepatitis Day 2022

PPA was delighted to support Hepatitis Australia raise awareness of this important issue in the first sitting week of the #47thparliament.

CAE Australia awards Women in Engineering Scholarship

Wonderful to see the announcement this morning from our client CAE Australia in their award of the CAE Australia Pty Ltd Women in Engineering Scholarship to undergraduate student Natalie Jordanov.

PPA Client Kyowa Kirin Receive Positive Recommendation for Crysvita

A massive congratulations to Precision Public Affairs client Kyowa Kirin Asia Pacific and Simon Dawson and the Australian KK team for receiving a positive recommendation from the May PBAC meeting for Crysvita, treating X-linked hypophosphataemia (XLH).